VACCINEX, INC. (VCNX)
Vaccinex, Inc. is a biotechnology firm operating in the clinical stage, dedicated to identifying and developing specialized biological therapies. Its core mission is to address serious medical conditions and diseases that currently lack adequate treatment options. The company's therapeutic endeavors encompass a broad spectrum of illnesses, including various forms of cancer, neurodegenerative disorders, and autoimmune diseases. At the forefront of its pipeline is pepinemab, a humanized monoclonal antibody. This leading candidate has either concluded or is scheduled for Phase 1b/2 clinical investigations, exploring its efficacy against non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. Furthermore, Vaccinex is progressing with VX5, a human antibody targeting CXCL13, which is presently in preclinical assessment for potential application in multiple sclerosis (MS) and other autoimmune conditions. The company was established in 2001 and has its principal operations located in Rochester, New York.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Vaccinex, Inc.
OTC:VCNXHealthcare · Biotechnology
+17.20%$0.8205
Mkt Cap$2.2M
Float647K
O/S2.68M
Inst Own-
SI0.4%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$2.1M
Net Income-$5.26M
Total Assets$1.8M
Free Cash Flow-$6.46M
Debt & Equity
Total Debt$5.52M
Total Equity-$7.59M
Preferred Stock$1.81M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
- 1:14Reverse splitFeb 20, 202414 shares → 1
- 1:15Reverse splitSep 26, 202315 shares → 1
Balance Sheet Details
Assets$1.8M
Liabilities$9.39M
Accounts Receivable$1.16M
Accounts Payable$3.47M
Inventory$0
PP&E (Net)$39K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $2.1M | $601K | $570K | $100K | $900K | $50K | $523K | $724K | $90K | $316K |
| YoY Growth | 248.6% | 5.4% | 470.0% | -88.9% | 1700.0% | -90.4% | -27.8% | 704.4% | -71.5% | - |
| Cost of Revenue | $35K | $0 | $0 | $207K | $169K | $2K | $199K | $1.03M | $160K | $115K |
| Gross Profit | $2.06M | $601K | $570K | $68K | $731K | $48K | $324K | -$309K | -$70K | $201K |
| Gross Margin | 98.3% | 100.0% | 100.0% | 68.0% | 81.2% | 96.0% | 62.0% | -42.7% | -77.8% | 63.6% |
| Research and Development | $4.22M | $12.54M | $16.57M | $13.98M | $17.16M | $21.55M | $25.67M | $22.35M | $16.55M | $16.03M |
| Selling, General, and Administrative | $3.08M | $6.79M | $6.88M | $6.2M | $6.23M | $7.41M | $6.67M | $4.62M | $4.48M | $4.43M |
| Other | $0 | $0 | $0 | -$175K | -$169K | -$575K | $0 | $165K | -$40K | -$4K |
| Total Operating Expenses | $7.29M | $19.34M | $23.45M | $20.01M | $23.22M | $28.38M | $32.34M | $26.97M | $21.03M | $20.46M |
| Operating Income (EBIT) | -$5.23M | -$18.73M | -$22.89M | -$19.91M | -$22.49M | -$28.33M | -$32.02M | -$27.28M | -$21.1M | -$20.26M |
| Operating Margin | -249.7% | -3117.3% | -4014.9% | -19906.0% | -2498.9% | -56662.0% | -6121.4% | -3768.1% | -23448.9% | -6411.1% |
| Interest Expense | $132K | $2K | $1K | $2K | $809K | $489K | $0 | $392K | $1.36M | $2.99M |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$28K | $101K | $2.63M | $91K | $110K | -$520K | $152K | -$2.24M | $2.35M | $6.32M |
| Income Before Tax (EBT) | -$5.26M | -$18.63M | -$20.25M | -$19.82M | -$22.38M | -$28.85M | -$31.86M | -$29.52M | -$18.76M | -$13.94M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5.26M | -$18.63M | -$20.25M | -$19.72M | -$22.38M | -$28.85M | -$32.02M | -$29.52M | -$18.72M | -$13.94M |
| Net Income Margin | -251.1% | -3100.5% | -3552.8% | -19722.0% | -2486.7% | -57702.0% | -6121.4% | -4077.1% | -20802.2% | -4412.3% |
| Supplementary Data | ||||||||||
| EPS | -1.97 | -8.88 | -43.68 | -97.59 | -163.80 | -322.50 | -521.95 | -1186.70 | -689.86 | -526.85 |
| Diluted EPS | -1.97 | -8.88 | -43.68 | -97.59 | -162.91 | -322.50 | -521.95 | -1186.70 | -689.86 | -526.85 |
| Weighted Average OS | 2.68M | 2.10M | 463,650 | 202,082 | 136,630 | 89,461 | 61,337 | 24,874 | 27,139 | 26,465 |
| EBITDA | -$5.2M | -$18.54M | -$19.75M | -$19.61M | -$21.4M | -$28.05M | -$31.61M | -$28.9M | -$17.2M | -$10.78M |
| EBITDA Margin | -248.1% | -3084.5% | -3464.6% | -19606.0% | -2378.0% | -56110.0% | -6044.7% | -3992.1% | -19105.6% | -3409.8% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $140K | $1.11M | $1.53M | $6.39M | $8.59M | $10.6M | $2.78M | $5.62M | $4.18M | $1.66M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14.11M | $0 | $0 |
| Cash and Short-Term Investments | $140K | $1.11M | $1.53M | $6.39M | $8.59M | $10.6M | $2.78M | $19.72M | $4.18M | $1.66M |
| Accounts Receivable | $1.16M | $838K | $961K | $175K | $0 | $157K | $898K | $639K | $117K | $104K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $465K | $586K | $853K | $912K | $816K | $0 | $0 | $1.06M | $0 | $0 |
| Total Current Assets | $1.76M | $2.53M | $3.35M | $7.48M | $9.4M | $11.29M | $4.01M | $21.42M | $4.97M | $2.11M |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $39K | $65K | $282K | $499K | $438K | $416K | $594K | $604K | $601K | $730K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $39K | $65K | $282K | $499K | $438K | $416K | $594K | $604K | $601K | $730K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.8M | $2.6M | $3.63M | $7.98M | $9.84M | $11.7M | $4.6M | $22.03M | $5.58M | $2.84M |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $3.47M | $3.96M | $2.04M | $1.52M | $1.06M | $3.17M | $3.21M | $2.32M | $1.91M | $2.46M |
| Short-Term Debt | $0 | $25K | $75K | $74K | $74K | $8.07M | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $96K | $0 | $63K | $0 | $0 | $0 | $0 | $0 | $298K | $0 |
| Other Current Liabilities | $58K | $881K | $3.3M | $473K | $571K | $1.51M | $0 | $4.07M | $1.65M | $1.67M |
| Total Current Liabilities | $3.87M | $5.08M | $5.92M | $2.54M | $2.26M | $13.18M | $6.88M | $6.69M | $4.17M | $4.44M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $5.52M | $0 | $26K | $101K | $175K | $1.13M | $0 | $0 | $2.81M | $1.04M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $369K | $694K |
| Total Long-Term Liabilities | $5.52M | $0 | $26K | $247K | $175K | $1.13M | $3.67M | $0 | $3.18M | $1.73M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | -$3.67M | $0 | $0 | $0 |
| Total Liabilities | $9.39M | $5.08M | $5.94M | $2.78M | $2.43M | $14.31M | $6.88M | $6.69M | $7.35M | $6.17M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $1.81M | $1.67M | $0 | $0 | $0 | $0 | $4.6M | $0 | $119.4M | $111.42M |
| Common Stock | $1K | $1K | $0 | $5K | $3K | $3K | $1K | $1K | $0 | $1K |
| Retained Earnings | -$363.82M | -$358.56M | -$339.93M | -$319.68M | -$299.86M | -$277.48M | -$248.63M | -$216.77M | -$187.25M | -$168.53M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | -$4.6M | -$6.32M | -$6.1M | -$5.89M |
| Other Stockholders' Equity | $356.23M | $356.07M | $337.62M | $324.86M | $307.27M | $250.9M | $222.39M | $208.15M | $173.51M | $165.2M |
| Total Equity | -$7.59M | -$2.49M | -$2.31M | $5.19M | $7.41M | -$26.57M | -$26.24M | -$8.62M | -$13.73M | -$3.33M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $23.96M | $23.96M | $23.96M | $11.96M | $0 |
| Total Liabilities and Equity | $1.8M | $2.6M | $3.63M | $7.98M | $9.84M | -$12.26M | -$19.36M | -$1.94M | -$6.39M | $2.84M |
| Supplementary Data | ||||||||||
| Total Debt | $5.52M | $25K | $247K | $485K | $390K | $9.21M | $0 | $0 | $2.81M | $1.04M |
| Net Debt | $5.38M | -$1.08M | -$1.29M | -$5.91M | -$8.2M | -$1.39M | -$2.78M | -$5.62M | -$1.37M | -$624K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$5.26M | -$18.63M | -$20.25M | -$19.82M | -$22.38M | -$28.85M | -$31.86M | -$29.52M | -$18.76M | -$13.94M |
| Depreciation & Amortization | $35K | $94K | $119K | $207K | $169K | $307K | $249K | $223K | $206K | $178K |
| Deferred Income Tax | $0 | $0 | $0 | -$677K | -$876K | -$65K | $0 | $1.91M | -$3.74M | -$9.31M |
| Stock-Based Compensation | $0 | $341K | $474K | $545K | $541K | $732K | $447K | $177K | $319K | $135K |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | -$317K | $123K | -$786K | -$175K | $157K | $741K | -$260K | -$522K | -$13K | -$85K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.02M | -$357K | $3.66M |
| Accounts Payable | -$487K | $1.91M | $521K | $457K | -$2.11M | $122K | $725K | $421K | -$555K | $407K |
| Other Working Capital | -$578K | $66K | $583K | -$293K | -$1.26M | -$1.93M | $31K | -$298K | $298K | -$2.33M |
| Total Working Capital Change | -$1.38M | $2.1M | $318K | -$11K | -$3.21M | -$1.07M | $496K | $1.62M | -$627K | $1.65M |
| Other Non-Cash Items | $157K | -$90K | $2.11M | $677K | $458K | $297K | -$44K | $308K | $1.22M | $1.57M |
| Net Cash from Operating | -$6.45M | -$16.19M | -$17.23M | -$19.07M | -$25.3M | -$28.65M | -$30.71M | -$25.28M | -$21.39M | -$19.72M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$9K | -$22K | -$67K | -$99K | -$32K | -$290K | -$78K | -$235K | -$68K | -$793K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$20.76M | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $14.15M | $6.75M | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$14.01M | $0 | $0 |
| Net Cash from Investing | -$9K | -$22K | -$67K | -$99K | -$32K | -$290K | $14.07M | -$14.24M | -$68K | -$793K |
| Financing Activities | ||||||||||
| Debt Repaid | -$5.49M | $76K | $74K | $75K | $8.54M | -$9.03M | - | $5.5M | -$3.98M | -$5.68M |
| Common Stock Issuance | $0 | $7.13M | $12.52M | $17.05M | $32.85M | $28.48M | $13.8M | $37.13M | $8M | $10.68M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $7.03M | $0 | $0 | -$985K | -$744K | $0 | $9.33M | $12.02M | $10.68M |
| Net Cash from Financing | $5.49M | $15.78M | $12.45M | $16.98M | $23.32M | $36.76M | $13.8M | $40.95M | $23.97M | $16.36M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$967K | -$428K | -$4.86M | -$2.2M | -$2.01M | $7.82M | -$2.84M | $1.44M | $2.52M | -$4.16M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$6.45M | -$16.19M | -$17.23M | -$19.07M | -$25.3M | -$28.65M | -$30.71M | -$25.28M | -$21.39M | -$19.72M |
| Capital Expenditure | -$9K | -$22K | -$67K | -$99K | -$32K | -$290K | -$78K | -$235K | -$68K | -$793K |
| Free Cash Flow | -$6.46M | -$16.21M | -$17.3M | -$19.17M | -$25.33M | -$28.94M | -$30.79M | -$25.51M | -$21.45M | -$20.51M |
| Cash at Beginning | $1.11M | $1.53M | $6.39M | $8.59M | $10.6M | $2.78M | $5.62M | $4.18M | $1.66M | $5.82M |
| Cash at End | $140K | $1.11M | $1.53M | $6.39M | $8.59M | $10.6M | $2.78M | $5.62M | $4.18M | $1.66M |